Login to Your Account

Other News To Note

Tuesday, November 26, 2013
• Cerecor Inc., of Baltimore, received fast-track designation from the FDA for CERC-301 , its candidate for major depressive disorder.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription